Solid Biosciences (SLDB) EBT Margin (2022 - 2024)
Historic EBT Margin for Solid Biosciences (SLDB) over the last 3 years, with Q4 2024 value amounting to 50728.0%.
- Solid Biosciences' EBT Margin changed N/A to 50728.0% in Q4 2024 from the same period last year, while for Dec 2024 it was 35470.29%, marking a year-over-year decrease of 447859000.0%. This contributed to the annual value of 35470.29% for FY2024, which is N/A changed from last year.
- Per Solid Biosciences' latest filing, its EBT Margin stood at 50728.0% for Q4 2024.
- Solid Biosciences' EBT Margin's 5-year high stood at 50728.0% during Q4 2024, with a 5-year trough of 406.69% in Q2 2022.
- In the last 3 years, Solid Biosciences' EBT Margin had a median value of 27173.88% in 2024 and averaged 28319.87%.
- Within the past 5 years, the most significant YoY rise in Solid Biosciences' EBT Margin was 5009700bps (2024), while the steepest drop was 5009700bps (2024).
- Quarter analysis of 3 years shows Solid Biosciences' EBT Margin stood at 406.69% in 2022, then surged by 6268bps to 25084.3% in 2023, then surged by 102bps to 50728.0% in 2024.
- Its last three reported values are 50728.0% in Q4 2024, 40165.85% for Q3 2024, and 28762.5% during Q2 2024.